Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus.
作者信息
Alexander W D, Wensley R T, Price G, Hartog M
出版信息
Postgrad Med J. 1976 May;52(607):251-3. doi: 10.1136/pgmj.52.607.251.
Abstract
This study was performed to assess the effect of chlorpropamide therapy on the fibrinolytic activity of blood of maturity onset diabetics. Normal controls were also studied and the results compared with diabetics. Diabetics were found to have deficient fibrinolytic activity compared with non-diabetics but chlorpropamide did not appear significantly to affect this deficiency either in males or females when given therapeutically over a 6-month period.
摘要
相似文献
1
Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus.
Postgrad Med J. 1976 May;52(607):251-3. doi: 10.1136/pgmj.52.607.251.
2
Fibrinolytic activity in diabetics before and after chlorpropamide therapy.
J Assoc Physicians India. 1978 May;26(5):375-8.
3
Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
Pol J Pharmacol Pharm. 1984 Sep-Oct;36(5):449-53.
4
Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.
Thromb Res. 1984 Jul 1;35(1):19-25. doi: 10.1016/0049-3848(84)90309-8.
5
[Effect of sulfonylureas on lipid levels in diabetic patients].
Rass Int Clin Ter. 1968 Apr 30;48(8):455-62.
6
Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
Diabetologia. 1977 Aug;13(4):367-71. doi: 10.1007/BF01223280.
7
[Antidiuretic action of chlorpropamide (Diabinese) in a case of combined diabetes mellitus and diabetes insipidus].
Probl Endokrinol (Mosk). 1972 Mar-Apr;18(2):63-5.
8
Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
Acta Endocrinol Suppl (Copenh). 1980;239:53-5.
9
Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.
Diabetes. 1967 Jul;16(7):487-92. doi: 10.2337/diab.16.7.487.
10
Letter: Treatment of maturity-onset diabetes.
Lancet. 1975 Mar 8;1(7906):580-1. doi: 10.1016/s0140-6736(75)91606-2.
引用本文的文献
1
Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.
Med Toxicol. 1987 May-Jun;2(3):190-209. doi: 10.1007/BF03259864.
本文引用的文献
1
FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS.
Scott Med J. 1964 Sep;9:359-64. doi: 10.1177/003693306400900901.
2
PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD.
J Clin Pathol. 1964 May;17(3):328-32. doi: 10.1136/jcp.17.3.328.
3
Clearing factor, fibrinolysis and blood lipids in diabetes mellitus.
Clin Sci. 1962 Dec;23:485-8.
4
Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity.
Br Med J. 1963 Apr 6;1(5335):921-3. doi: 10.1136/bmj.1.5335.921.
5
The effects of chlorpropamide on intermittent claudication and fibrinolysis.
Lancet. 1962 Jun 9;1(7241):1213-5. doi: 10.1016/s0140-6736(62)92255-9.
6
An improved plasma recalcified clotting test and its modification as a simple rapid heparin retarded clotting test.
J Clin Pathol. 1962 Jan;15(1):86-7. doi: 10.1136/jcp.15.1.86.
7
Reduction of blood fibrinolytic activity in diabetes mellitus by insulin.
Lancet. 1959 Dec 12;2(7111):1067. doi: 10.1016/s0140-6736(59)91534-x.
8
Blood lipids, mucoproteins, and fibrinolytic activity in diabetic Indians and Africans in Natal. Possible relation to vascular complications.
Lancet. 1961 Jun 17;1(7190):1314-8. doi: 10.1016/s0140-6736(61)90239-2.
9
Effect of the sulphonylureas on fibrinolysis.
Lancet. 1960 Sep 17;2(7151):622-5. doi: 10.1016/s0140-6736(60)91694-9.
Zotero 插件